膈肌无力可能解释COVID-19住院后15个月的劳力性呼吸困难
研究纳入50例既往因COVID-19住院的患者(14例女性,年龄58±12岁,一半接受机械通气、一半在ICU外治疗),在出院15个月时进行肺功能、6分钟步行试验、超声心动图、颈磁刺激膈神经根后颤搐跨膈压及膈肌超声检查,并与健康对照组比较。约三分之二患者存在中重度劳力性呼吸困难,肺功能和超声心动图未见明显异常。机械通气患者颤搐跨膈压14±8 vs 对照21±3 cm H2O(P=0.02),未通气患者15±8 vs 对照21±3 cm H2O(P=0.04),且颤搐跨膈压与劳力性呼吸困难严重程度显著相关(P=0.03)。作者认为膈肌无力是肺和心脏功能正常的COVID-19后持续呼吸困难的相关因素。
要点
- COVID-19住院后15个月,约三分之二患者存在中重度劳力性呼吸困难,肺功能与超声心动图未见明显异常。
- 机械通气患者颤搐跨膈压14±8 vs 对照21±3 cm H2O(P=0.02),未通气患者15±8 vs 对照21±3 cm H2O(P=0.04)。
- 膈肌无力独立于初始疾病严重程度,未接受机械通气的患者同样存在。
- 颤搐跨膈压与劳力性呼吸困难严重程度显著相关(P=0.03)。
- 对肺和心脏功能正常但持续呼吸困难的COVID-19后患者,作者认为膈肌无力是相关因素。
适用人群与场景
- 50例既往因COVID-19住院的患者,14例女性,年龄58±12岁,一半接受机械通气、一半在ICU外治疗,出院后15个月评估。
- 健康对照组用于膈肌功能数据比较。
研究设计与关键结果
- 研究类型为病例对照式评估:50例既往COVID-19住院患者出院15个月时接受肺功能、6分钟步行试验、超声心动图、颈磁刺激膈神经根后颤搐跨膈压及膈肌超声检查,并与健康对照组比较。
- 约三分之二患者在出院15个月时存在中重度劳力性呼吸困难,未检测到明显的肺功能或超声心动图异常。
- 颤搐跨膈压:机械通气患者14±8 vs 对照21±3 cm H2O(P=0.02);未通气患者15±8 vs 对照21±3 cm H2O(P=0.04)。
- 颤搐跨膈压与劳力性呼吸困难严重程度显著相关(P=0.03)。
证据类型、等级与局限
- 证据类型:病例对照式评估(患者与健康对照组比较)。
- 临床试验注册号:NCT04854863。
- 局限:原文未报告局限性。
对床旁实践的改变
- 对COVID-19住院后肺功能和心脏功能正常但持续劳力性呼吸困难的患者,作者认为膈肌无力是相关因素,可解释其呼吸困难。
- 膈肌无力可见于未接受机械通气的患者,评估时不应仅局限于机械通气患者。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
Rationale: Dyspnea is often a persistent symptom after acute coronavirus disease (COVID-19), even if cardiac and pulmonary function are normal. Objectives: This study investigated diaphragm muscle strength in patients after COVID-19 and its relationship to unexplained dyspnea on exertion. Methods: Fifty patients previously hospitalized with COVID-19 (14 female, age 58 ± 12 yr, half of whom were treated with mechanical ventilation, and half of whom were treated outside the ICU) were evaluated using pulmonary function testing, 6-minute-walk test, echocardiography, twitch transdiaphragmatic pressure after cervical magnetic stimulation of the phrenic nerve roots, and diaphragm ultrasound. Diaphragm function data were compared with values from a healthy control group. Measurements and Main Results: Moderate or severe dyspnea on exertion was present at 15 months after hospital discharge in approximately two-thirds of patients. No significant pulmonary function or echocardiography abnormalities were detected. Twitch transdiaphragmatic pressure was significantly impaired in patients previously hospitalized with COVID-19 compared with control subjects, independent of initial disease severity (14 ± 8 vs. 21 ± 3 cm H2O in mechanically ventilated patients vs. control subjects [P = 0.02], and 15 ± 8 vs. 21 ± 3 cm H2O in nonventilated patients vs. control subjects [P = 0.04]). There was a significant association between twitch transdiaphragmatic pressure and the severity of dyspnea on exertion (P = 0.03). Conclusions: Diaphragm muscle weakness was present 15 months after hospitalization for COVID-19 even in patients who did not require mechanical ventilation, and this weakness was associated with dyspnea on exertion. The current study, therefore, identifies diaphragm muscle weakness as a correlate for persistent dyspnea in patients after COVID-19 in whom lung and cardiac function are normal. Clinical trial registered with www.clinicaltrials.gov (NCT04854863).
参考来源
- Regmi B, Friedrich J, Jörn B, et al. Diaphragm Muscle Weakness Might Explain Exertional Dyspnea 15 Months after Hospitalization for COVID-19. Am J Respir Crit Care Med. 2023. PMID: 36596223. doi:10.1164/rccm.202206-1243OC
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。